Business
BURCON ANNOUNCES YEAR-END RESULTS, UPDATES ON ACTIVITIES
Jun. 22, 2011 (Canada NewsWire Group) -- VANCOUVER, June 22, 2011 /CNW/ - Burcon NutraScience...
About this update from Burcon Nutrascience Corporation
[{"type":"text","content":"\n\n\n Jun. 22, 2011 (Canada NewsWire Group) -- \n\n#ReleaseContent TABLE\n{\n BORDER-COLLAPSE: collapse\n}\nTR.cnwUnderlinedCell TD\n{\n BORDER-BOTTOM: #000000 1px solid\n}\nTR.cnwDoubleUnderlinedCell TD\n{\n BORDER-BOTTOM: #000000 3px double\n}\nTR.cnwBoldUnderlinedCell TD\n{\n BORDER-BOTTOM: #000000 3px solid\n}\nTD.cnwUnderlinedCell\n{\n BORDER-BOTTOM: #000000 1px solid\n}\nTD.cnwDoubleUnderlinedCell\n{\n BORDER-BOTTOM: #000000 3px double\n}\nTD.cnwBoldUnderlinedCell\n{\n BORDER-BOTTOM: #000000 3px solid\n}\n#ReleaseContent TABLE.cnwBorderedTable TD\n{\n BORDER-RIGHT: black 1px solid;\n PADDING-RIGHT: 2px;\n BORDER-TOP: black 1px solid;\n PADDING-LEFT: 2px;\n PADDING-BOTTOM: 2px;\n BORDER-LEFT: black 1px solid;\n PADDING-TOP: 2px;\n BORDER-BOTTOM: black 1px solid;\n BORDER-COLLAPSE: collapse\n}\n#ReleaseContent TABLE TD\n{\n PADDING-RIGHT: 2px;\n PADDING-LEFT: 2px;\n PADDING-BOTTOM: 2px;\n PADDING-TOP: 2px\n}\n\n\nVANCOUVER, June 22, 2011 /CNW/ - Burcon NutraScience Corporation (TSX -\n BU) ("Burcon") today reported financial results for the fiscal year\n ended March 31, 2011 and provided a review of the year's operations.\n\n\nA summary of the highlights of the past year includes:\n\n\n\nReceived a no objection letter from the U.S. Food and Drug\n Administration (FDA) that Puratein® and Supertein™ are GRAS (Generally Recognized As Safe) under their intended conditions\n of use;\n\n\nHeld discussions, supported due diligence activities, and negotiated\n possible business structures with a short list of potential strategic\n alliance partners for the commercialization of CLARISOY® soy protein;\n\n\nEntered into a License and Production Agreement with ADM for the\n worldwide production, marketing and sale of Burcon's CLARISOY® soy protein;\n\n\nFiled several patent applications over newly developed novel processes\n for the production, functional and nutritional applications of, and\n functional attributes of CLARISOY® soy protein;\n\n\nGranted 13 U.S. patents over Burcon's canola and flax protein patent\n applications;\n\n\nRaised $1,867,000 through the exercise of incentive stock options and\n agents' compensation options.\n\n\n\nSince the announcement of CLARISOY®, Burcon has undertaken numerous activities in the pursuit of\n establishing a strategic alliance for the commercializati...